Altimmune
ALT
ALT
171 hedge funds and large institutions have $213M invested in Altimmune in 2026 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 82 increasing their positions, 34 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
6% less funds holding
Funds holding: 181 → 171 (-10)
15% less first-time investments, than exits
New positions opened: 29 | Existing positions closed: 34
Holders
171
Holding in Top 10
–
Calls
$10.4M
Puts
$3.21M
Top Buyers
| 1 | +$13.1M | |
| 2 | +$13.1M | |
| 3 | +$13M | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
+$11.2M |
| 5 |
State Street
Boston,
Massachusetts
|
+$8.6M |
Top Sellers
| 1 | -$7.57M | |
| 2 | -$6.22M | |
| 3 | -$4.08M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$3.77M |
| 5 |
D.E. Shaw & Co
New York
|
-$2.62M |
